Keros Therapeutics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Keros Therapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $244.06 million for the year ending 2025.

  • Keros Therapeutics, Inc. showed an increase of +6,775.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from Keros Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Keros Therapeutics, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 2,340.6%.
  • Historical annual values: Fiscal year 2025: $244.06 million | Fiscal year 2024: $3.55 million | Fiscal year 2023: $151.0 thousand | Fiscal year 2022: $0.00 | Fiscal year 2021: $20.10 million | Fiscal year 2020: $0.00 | Fiscal year 2019: $10.00 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: